Novo Nordisk Annual Report 2021

Contents Introducing Novo Nordisk Strategic Aspirations Key risks Management Consolidated statements Additional information Novo Nordisk Annual Report 2021 49 Consolidated financial, environmental, social and governance statements 2021 Consolidated statements Income statement Cash flow statement p. 50 p. 51 Section 4 Capital structure and financial items 4.1 Distribution to shareholders Consolidated ESG statement p. 85 Balance sheet Equity statement p. 52 p. 53 4.2 4.3 Share capital, Treasury shares and Other reserves Financial risks p. 68 Notes to the consolidated ESG statement p. 68 p. 69 Section 6 4.4 Derivative financial instruments Notes to the consolidated financial statements p. 71 4.5 Basis of preparation Borrowings p. 86 p. 72 4.6 Section 1 Cash and cash equivalents p. 73 Section 7 4.7 Other non-cash items p. 73 Basis of preparation 4.8 Change in working capital Environmental performance p. 73 1.1 Principal accounting policies and key accounting estimates 1.2 Changes in accounting policies and disclosures p. 54 p. 54 4.9 Financial assets and liabilities p. 74. 4.10 Financial income and expenses p. 75 7.1 Energy consumption for operations and share of renewable power p. 87 7.2 Water consumption for production sites Section 2 Results for the year 2.1 Net sales and rebates 2.2 Segment information p. 87 Section 5 Other disclosures p. 55 5.1 Share-based payment schemes p. 76 7.3 Breaches of environmental regulatory limit values 7.4 CO, emissions from operations and transportation 7.5 Waste from production sites p. 87 p. 87 p. 88 p. 56 5.2 Commitments 2.3 Research and development costs p. 78 p. 58 5.3 Acquisition of businesses Section 8 p. 78 2.4 Employee costs p. 58 5.4 Related party transactions p. 79 Social performance 2.5 Other operating income and expenses p. 59 5.5 Fee to statutory auditors p. 80 8.1 Patients reached with Novo Nordisk's Diabetes care products 2.6 Income taxes and deferred income taxes 2.7 Earnings per share p. 88 p. 59 5.6 General accounting policies p. 80 8.2 Employees p. 89 p. 60 5.7 Companies in the Novo Nordisk Group p. 81 8.3 Sustainable employer score p. 89 Section 3 8.4 Frequency of occupational accidents p. 89 8.5 Gender diversity Operating assets and liabilities p. 89 8.6 Total tax contribution p. 90 3.1 Intangible assets and property, plant and equipment p. 61 3.2 Inventories p. 3.3 Trade receivables p. 3.4 Provisions and contingent liabilities p. 3.5 Other liabilities p. 67 22220 Financial definitions 8.7 Supplier audits p. 90 65 (part of Management's review - not audited) Non-IFRS financial measures p. 82 Section 9 (part of Management's review - not audited) p. 83 Governance performance 9.1 Business ethics reviews and training p. 90 9.2 Supplier audits p. 90 9.3 Product recalls p. 91 9.4 Failed inspections p. 91 9.5 Facilitations of the Novo Nordisk Way p. 91 9.6 Company reputation p. 91 9.7 Animals purchased for research p. 91

View entire presentation